{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:05:00Z","timestamp":1787868300442,"version":"build-2784847793"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"am","delay-in-days":264,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejmech.2021.113685","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T00:20:35Z","timestamp":1625876435000},"page":"113685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies"],"prefix":"10.1016","volume":"224","author":[{"given":"Mohit K.","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Coghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3641-4814","authenticated-orcid":false,"given":"Prakhar","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra K.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Congling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinkar","family":"Sahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Kam","family":"Wai Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113685_bib1","series-title":"World Malaria Report: 2020","author":"WHO","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113685_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature15535","article-title":"The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015","volume":"526","author":"Bhatt","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113685_bib3a","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1021\/bi400557x","article-title":"Function of resistance conferring Plasmodium falciparum chloroquine resistance transporter isoforms","volume":"52","author":"Baro","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2021.113685_bib3b","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113685_bib3c","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41467-020-17781-6","article-title":"The natural function of the malaria parasite's chloroquine resistance transporter","volume":"11","author":"Shafik","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113685_bib3d","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14787210.2017.1313703","article-title":"pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies","volume":"15","author":"Gil","year":"2017","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ejmech.2021.113685_bib3e","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1186\/s12936-016-1595-9","article-title":"Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana","volume":"15","author":"Faway","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2021.113685_bib3f","doi-asserted-by":"crossref","first-page":"474","DOI":"10.4269\/ajtmh.2010.10-0004","article-title":"Mutations in the antifolate-resistance-associated genes dihydrofolate reductase and dihydropteroate synthase in Plasmodium vivax isolates from malaria-endemic countries","volume":"83","author":"Lu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2021.113685_bib3g","doi-asserted-by":"crossref","first-page":"35-47","DOI":"10.1016\/j.chom.2019.06.001","article-title":"Elucidating mechanisms of drug-resistant Plasmodium falciparum","volume":"26","author":"Ross","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2021.113685_bib3h","doi-asserted-by":"crossref","first-page":"104275","DOI":"10.1016\/j.phrs.2019.104275","article-title":"Development of artemisinin resistance in malaria therapy","volume":"146","author":"Na\u00df","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2021.113685_bib4a","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/med.21657","article-title":"Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: chronological advancements and future challenges","volume":"40","author":"Tiwari","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113685_bib4b","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/1568026619666190412104042","article-title":"Recent developments in natural product inspired synthetic 1,2,4- trioxolanes (ozonides): an unusual entry into antimalarial chemotherapy","volume":"19","author":"Tiwari","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrmicro.2017.161","article-title":"Drug resistance in plasmodium","volume":"16","author":"Haldar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113685_bib7a","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113685_bib7b","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00044-016-1736-2","article-title":"Cyclic peroxides as promising anticancer agents: in\u00a0vitro cytotoxicity study of synthetic ozonides and tetraoxanes on human prostate cancer cell lines","volume":"26","author":"Yaremenko","year":"2017","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113685_bib7c","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1039\/B816679J","article-title":"Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents","volume":"39","author":"Chaturvedi","year":"2010","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2021.113685_bib8a","doi-asserted-by":"crossref","first-page":"10111","DOI":"10.1038\/ncomms10111","article-title":"Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2021.113685_bib8b","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1871526513666131129155708","article-title":"Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses","volume":"13","author":"Haynes","year":"2013","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2021.113685_bib9a","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1021\/acs.jmedchem.5b01380","article-title":"Artemisinin-derived dimers: potent antimalarial and anticancer agents","volume":"59","author":"Fr\u00f6hlich","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib9b","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.25315","article-title":"First evidence that the antimalarial drug artesunate inhibits invasion and in\u00a0vivo metastasis in lung cancer by targeting essential extracellular proteases","volume":"127","author":"Rasheed","year":"2010","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113685_bib9c","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","article-title":"Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron","volume":"37","author":"Efferth","year":"2004","journal-title":"Radic Biol Med"},{"key":"10.1016\/j.ejmech.2021.113685_bib10a","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib10b","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1021\/jm3012068","article-title":"Principles and applications of halogen bonding in medicinal chemistry and chemical biology","volume":"56","author":"Wilcken","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib11a","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2014.09.049","article-title":"\u03b2-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents","volume":"87","author":"Sharma","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib11b","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1021\/ja3052427","article-title":"An asymmetric synthesis of 1,2,4-trioxane anticancer agents via desymmetrization of peroxyquinols through a Br\u00f8nsted acid catalysis cascade","volume":"134","author":"Rubush","year":"2012","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.113685_bib12a","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1039\/c39840000523","article-title":"Reactions of cyclic peroxides with aldehydes and ketones catalysed by trimethylsilyl trifluoromethanesulphonate. An efficient synthesis of 1,2,4-trioxanes","author":"Jefford","year":"1984","journal-title":"J.\u00a0Chem. Soc. Chem. Commun."},{"key":"10.1016\/j.ejmech.2021.113685_bib12b","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/hlca.19930760804","article-title":"Synthesis, structure, and antimalarial activity of tricyclic 1,2,4-trioxanes related to artemisinin","volume":"76","author":"Jefford","year":"1993","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.ejmech.2021.113685_bib12c","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/00034983.1993.11812734","volume":"87","author":"Peters","year":"1993","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.ejmech.2021.113685_bib13a","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/jm970686e","article-title":"Orally active antimalarial 3-substituted trioxanes: new synthetic methodology and biological evaluation","volume":"41","author":"Posner","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13b","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/jm970711g","article-title":"Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin","volume":"41","author":"Cumming","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13c","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1016\/S0040-4039(99)01892-4","article-title":"Asymmetric syntheses of enantiomeric 3-p-fluorophenyl 1,2,4-trioxane analogues of the antimalarial artemisinin","volume":"40","author":"O'Neill","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113685_bib13d","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1021\/jm9903545","article-title":"Novel, potent, semisynthetic antimalarial carba analogues of the first-generation 1,2,4-trioxane artemether","volume":"42","author":"O'Neill","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13e","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1021\/jm0102396","article-title":"Antimalarial simplified 3-aryltrioxanes: synthesis and preclinical efficacy\/toxicity testing in rodents","volume":"44","author":"Posner","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13f","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1021\/jm020210h","article-title":"Orally active, water-soluble antimalarial 3-aryltrioxanes: short synthesis and preclinical efficacy testing in rodents","volume":"45","author":"Posner","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13g","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ar020227u","article-title":"Knowledge of the proposed chemical mechanism of action and cytochrome P450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides","volume":"37","author":"Posner","year":"2004","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2021.113685_bib13h","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1021\/ol0492142","article-title":"Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore","volume":"6","author":"O'Neill","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113685_bib13i","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/cbic.200500048","article-title":"Enantiomeric 1,2,4-trioxanes display equivalent in\u00a0vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins","volume":"6","author":"O'Neill","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2021.113685_bib13j","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1021\/jm051130r","article-title":"Orally active 1,2,4-trioxanes: Synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant Plasmodium yoelii nigeriensis in mice1","volume":"49","author":"Singh","year":"2006","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13k","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.lfs.2007.09.023","article-title":"Evaluation of some adamantane-based synthetic trioxanes against Plasmodium knowlesi in rhesus monkeys","volume":"81","author":"Tripathi","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2021.113685_bib13l","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bmcl.2004.11.043","article-title":"Novel spiro-anellated 1,2,4-trioxanes with high in-vitro antimalarial activities","volume":"15","author":"Griesbeck","year":"2005","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113685_bib13m","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/157017806775789903","article-title":"Synthesis of polar antimalarial 1,2,4-trioxanes from C5-aldehyde and ipsdienol","volume":"3","author":"Griesbeck","year":"2006","journal-title":"Lett. Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13n","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1002\/anie.200701397","article-title":"Bicyclic peroxides and perorthoester with 1,2,4-trioxane structure","volume":"46","author":"Griesbeck","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2021.113685_bib13o","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1021\/jm9002523","article-title":"Antimalarial peroxide dyads from natural artemisinin and hydroxyalkylated 1,2,4-trioxanes","volume":"52","author":"Griesbeck","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13p","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3762\/bjoc.6.61","article-title":"Synthesis of spiroannulated and 3-arylated 1,2,4-trioxanes from mesitylol and methyl 4-hydroxytiglate by photooxygenation and peroxyacetalization","volume":"6","author":"Griesbeck","year":"2010","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib13q","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1039\/c3ra40555a","article-title":"Functionalized polar 1,2,4-trioxanes as building blocks by singlet oxygenation of 4-hydroxy tiglic acid using the deuterium isotope trick","volume":"3","author":"Griesbeck","year":"2013","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113685_bib13r","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/molecules22010119","article-title":"Synthetic approaches to mono- and bicyclic perortho-esters with a central 1,2,4-trioxane ring as the privileged lead structure in antimalarial and antitumor-active peroxides and clarification of the peroxide relevance","volume":"22","author":"Griesbeck","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113685_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bmcl.2005.10.044","article-title":"8-(1-Naphthalen-2-yl-vinyl)-6,7,10-trioxaspiro (4.5) decane, a new 1,2,4-trioxane effective against rodent and simian malaria","volume":"16","author":"Singh","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113685_bib15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/cmdc.202000045","article-title":"Design, synthesis, structure-activity relationship and docking studies of novel functionalized arylvinyl-1,2,4-trioxanes as potent antiplasmodial as well as anticancer agents","volume":"15","author":"Tiwari","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113685_bib16","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1016\/S0040-4039(00)97202-2","article-title":"Preparation of \u03b2-hydroxyhydroperoxides by photooxygenation of allylic alcohols and their elaboration into 1,2,4-trioxanes","volume":"31","author":"Singh","year":"1990","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.113685_bib17a","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0032-1333295","article-title":"Antiplasmodial activity and cytotoxicity of 10\u03b2-aminoquinolinylethylethers of artemisinin","volume":"63","author":"N\u2019Da","year":"2013","journal-title":"Drug Res."},{"key":"10.1016\/j.ejmech.2021.113685_bib17b","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1371\/journal.pbio.0030335","article-title":"Recombination hotspots and population structure in Plasmodium falciparum","volume":"3","author":"Mu","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejmech.2021.113685_bib18a","series-title":"Single ascending dose safety and pharmacokinetics of CDRI-97\/78: first-in-human study of a novel antimalarial drug Malaria Research and Treatment","first-page":"10","author":"Shafiq","year":"2014"},{"key":"10.1016\/j.ejmech.2021.113685_bib18b","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0031-1296177","article-title":"Pharmacokinetic study of the novel, synthetic trioxane antimalarial compound 97-78 in rats using an LC-MS\/MS method for quantification","volume":"61","author":"Singh","year":"2011","journal-title":"Arzneim. Forsch."},{"key":"10.1016\/j.ejmech.2021.113685_bib18c","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.jchromb.2009.05.044","article-title":"A\u00a0sensitive and selective liquid chromatographic tandem mass spectrometric assay for simultaneous quantification of novel trioxane antimalarials in different biomatrices using sample-pooling approach for high throughput pharmacokinetic studies","volume":"877","author":"Singh","year":"2009","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.ejmech.2021.113685_bib18d","unstructured":"C. Singh S.K. Puri, Substituted 1,2,4-trioxanes as antimalarial agents and a process of producing the substituted 1,2,4-trioxane US Patent 2001 6316493 B1."},{"key":"10.1016\/j.ejmech.2021.113685_bib19","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ja.2011.6","article-title":"Borrelidin, a potent antimalarial: stage-specific inhibition profile of synchronized cultures of Plasmodium falciparum","volume":"64","author":"Ishiyama","year":"2011","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2021.113685_bib20","first-page":"317","article-title":"Overview of the improvement of the ring-stage survival assay-a novel phenotypic assay for the detection of artemisinin-resistant Plasmodium falciparum","volume":"38","author":"Zhang","year":"2017","journal-title":"Zool. Res."},{"key":"10.1016\/j.ejmech.2021.113685_bib21a","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1002\/cmdc.201800579","article-title":"Orally effective aminoalkyl 10H-indolo[3,2-b]quinoline-11-carboxamide kills the malaria parasite by inhibiting host hemoglobin uptake","volume":"13","author":"Mudududdla","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113685_bib21b","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/00034983.1970.11686683","article-title":"The antimalarial activity of some quinolone esters","volume":"64","author":"Ryley","year":"1970","journal-title":"Ann Trop Med PH"},{"key":"10.1016\/j.ejmech.2021.113685_bib22a","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/01635581.2013.749290","article-title":"Selective cytotoxicity and combined effects of camptothecin or paclitaxel with sodium-R-alpha lipoate on A549 human non-small cell lung cancer cells","volume":"66","author":"Ibrahim","year":"2013","journal-title":"Nutr. Canc."},{"key":"10.1016\/j.ejmech.2021.113685_bib22b","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/bjc.1993.488","article-title":"Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines","volume":"68","author":"Liebmann","year":"1993","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2021.113685_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0304-3835(98)00388-7","article-title":"Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines","volume":"136","author":"Gagandeep","year":"1999","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejmech.2021.113685_bib24","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113685_bib25","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1074\/jbc.M110.210047","article-title":"Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production","volume":"286","author":"Hamacher-Brady","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.18520\/cs\/v111\/i6\/1071-1077","article-title":"The inhibitory mechanism of compound K on A549 lung cancer cells through EGF pathway: an in silico and in\u00a0vitro approach","volume":"111","author":"Castro-Aceituno","year":"2016","journal-title":"Curr. Sci."},{"key":"10.1016\/j.ejmech.2021.113685_bib27","first-page":"350","article-title":"Design, synthesis, and biological evaluation of novel 1,2,4-trioxanes as potential antimalarial agents: 1,2,4-trioxanes as potential antimalarial agents","author":"Gupta","year":"2017","journal-title":"Arch. Pharm. Chem. Life Sci"},{"key":"10.1016\/j.ejmech.2021.113685_bib28","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1128\/AAC.01868-12","article-title":"Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia","volume":"57","author":"Witkowski","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113685_bib29","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ejmech.2021.113685_bib30","series-title":"In Chemotherapy and Drug Resistance in Malaria","first-page":"64","author":"Peters","year":"1970"},{"key":"10.1016\/j.ejmech.2021.113685_bib31","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/cmdc.201700804","article-title":"Novel Peroxides as promising anticancer agents with unexpected depressed antimalarial activity","volume":"13","author":"Coghi","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2021.113685_bib32","doi-asserted-by":"crossref","first-page":"46265","DOI":"10.1074\/jbc.M207135200","article-title":"Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor","volume":"277","author":"Stamos","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113685_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2021.113685_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: a force field providing broad coverage of drug-like small molecules and proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.113685_bib35","series-title":"Small-Molecule Drug Discovery Suite 2018-1. New York, NY","author":"Schr\u00f6dinger","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113685_bib36","unstructured":"Release, S., 2: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2018. New York, NY, 2018."},{"key":"10.1016\/j.ejmech.2021.113685_bib37","series-title":"Epik, Schr\u00f6dinger","author":"Release","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113685_bib38","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1063\/1.449071","article-title":"The nose\u2013hoover thermostat","volume":"83","author":"Evans","year":"1985","journal-title":"J.\u00a0Chem. Phys."},{"key":"10.1016\/j.ejmech.2021.113685_bib39","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1103\/PhysRevE.50.3234","article-title":"Remarks on \u201cConstant-temperature molecular dynamics with momentum conservation\u201d","volume":"50","author":"Martyna","year":"1994","journal-title":"Phys. Rev. E"},{"key":"10.1016\/j.ejmech.2021.113685_bib40","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1016\/S0969-2126(99)80033-1","article-title":"New tricks for modelers from the crystallography toolkit: the particle mesh Ewald algorithm and its use in nucleic acid simulations","volume":"7","author":"Darden","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2021.113685_bib41","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1021\/ct900587b","article-title":"Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field","volume":"6","author":"Shivakumar","year":"2010","journal-title":"Journal of chemical theory and computation. J. Chem. Theory Comput"},{"key":"10.1016\/j.ejmech.2021.113685_bib42","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins: Structure, Function, and Bioinformatics"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:31:32Z","timestamp":1759329092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":81,"alternative-id":["S0223523421005341"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113685","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel halogenated arylvinyl-1,2,4 trioxanes as potent antiplasmodial as well as anticancer agents: Synthesis, bioevaluation, structure-activity relationship and in-silico studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113685","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113685"}}